pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,050 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: recall×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07524023: Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

    Sponsor: University of Zurich. Phase: NA. Conditions: COPD, COPD (Chronic Obstructive Pulmonary Disease)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04702880: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Extensive-stage Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001979: Immune System Related Kidney Disease

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Kidney Disease, Nephrotic Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06681246: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

    Sponsor: Weizmann Institute of Science. Phase: NA. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00582296: Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Lynch Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05362903: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07413042: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

    Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE1. Conditions: SCLC, Extensive Stage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05932342: Improving Cognition of Older Adults in Community Housing

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Aging, Mental Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07218770: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469969: Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus

    Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: NA. Conditions: Chronic Subjective Tinnitus

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

    Sponsor: argenx. Phase: PHASE3. Conditions: Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05302583: Aromatherapy Inhaler Use for HSCT Distress

    Sponsor: Stanford University. Phase: NA. Conditions: Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03648905: Clinical Laboratory Evaluation of Chronic Autonomic Failure

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06642805: Bilio-pancreatic Complications of Congenital Duodenal Obstructions

    Sponsor: University Hospital, Angers. Phase: . Conditions: Duodenal Obstruction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06752356: A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Sponsor: Kedrion S.p.A.. Phase: PHASE3. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06265051: Tirofiban After Successful MT Recanalization in AIS

    Sponsor: Xiang Luo. Phase: PHASE2. Conditions: Acute Ischemic Stroke, Vessel Occlusion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06553131: Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

    Sponsor: Loma Linda University. Phase: . Conditions: Neuromuscular Blockade

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539129: Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Acne Vulgaris

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04644029: Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07320053: Effect of Longitudinal Care in Primary Health Care: An Analysis From the Patient's Perspective

    Sponsor: IBS Granada. Phase: . Conditions: Age 65 and Older, Polypharmacy, Cronic Lung Disease, Mental Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854653: A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

    Sponsor: Prescient Therapeutics, Ltd.. Phase: PHASE2. Conditions: CTCL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07227337: Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Post Traumatic Stress Disorder, Depression, Violence

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04021537: Non-invasive Nerve Stimulation and Sleep

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07614672: Effects Of Instrument Assisted Soft Tissue Mobilization as Compared With Manual Longitudinal Friction Massage in Individuals With Plantar Fasciitis.

    Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Plantar Fasciitis of Both Feet

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07052253: A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

    Sponsor: Akeso. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310953: Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management of Rescue Analgesia in Acute Postoperative Pain. Randomized Study.

    Sponsor: Fundacin Biomedica Galicia Sur. Phase: NA. Conditions: Analgesia, Post Operative Pain, Acute Pain, Functional; Anesthesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06135753: Psychosomatic Intervention in Fibromyalgia.

    Sponsor: University of Florence. Phase: NA. Conditions: Fibromyalgia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03384537: Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash

    Sponsor: Cairo University. Phase: EARLY_PHASE1. Conditions: Dental Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07404345: Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

    Sponsor: Hospital Civil de Guadalajara. Phase: PHASE4. Conditions: Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07536139: COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCE

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: NA. Conditions: Urge Urinary Incontinence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462039: Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

    Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Nurse's Role, Pain Management, Cervical Cancer Screening, Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07555639: An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06737432: Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

    Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Ventilation, ARDS, Respiratory Failure, Mechanical Ventilation, Ventilator-induced Lung Injury (VILI), Quality Improvement, Ventilator Associated Events

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE3. Conditions: Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07205198: A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

    Sponsor: Shanghai Institute Of Biological Products. Phase: PHASE1. Conditions: Advanced Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06321198: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

    Sponsor: Anhui Provincial Hospital. Phase: NA. Conditions: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06264063: Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia

    Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Dystonia, Neurologic Disorder, NEUROSCIENCE

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02799004: How Much Opioids Do You Need After Your Emergency Department Visit

    Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Phase: . Conditions: Acute Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07141004: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

    Sponsor: Johnson & Johnson Private Limited. Phase: PHASE4. Conditions: Arthritis, Psoriatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07132684: Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE3. Conditions: AML, Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07466433: Apical Preparation Size in Regenerative Endodontics of Mature Teeth

    Sponsor: Marmara University. Phase: NA. Conditions: Apical Periodontitis, Mature Teeth, Regenerative Endodontic Treatment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372352: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Peripheral T Cells Lymphoma (PTCL)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06974149: Effects of Transcranial Direct Current Stimulation Associated With Neurofunctional Rehabilitation in Individuals With Spinocerebellar Ataxias

    Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Ataxias Espinocerebelares

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05751655: Observational Study of Drowning Patient's Emergency Care in Its Pre-hospital Phase.

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: . Conditions: Drowning

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07602855: A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05500326: Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

    Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: Scabies; Itch, Scabies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

    Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06258278: Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

    Sponsor: Gazi University. Phase: NA. Conditions: Massive Irreparable Rotator Cuff Tears

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Solid Cancer, Metastatic Solid Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05972343: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

    Sponsor: Washington University School of Medicine. Phase: . Conditions: Breast Cancer, Cancer of the Breast

    full page →ctgov ↗
    ← prev
    page 48 of 101
    next →